scholarly journals Human Fetal Cell Therapy in Huntington's Disease: A Randomized, Multicenter, Phase II Trial

2020 ◽  
Vol 35 (8) ◽  
pp. 1323-1335 ◽  
Author(s):  
Anne‐Catherine Bachoud‐Lévi ◽  
Catherine Schramm ◽  
Philippe Remy ◽  
Ghislaine Aubin ◽  
Serge Blond ◽  
...  
Keyword(s):  
Cell Therapy ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Fetal Cell ◽  
Multicenter Phase

Q23 A double blind, cross over, placebo-controlled, phase II trial of Sativex in Huntington's Disease

2012 ◽  
Vol 83 (Suppl 1) ◽  
pp. A62.2-A62 ◽  
Author(s):  
JG Caldentey ◽  
JL Lopéz-Sendón ◽  
P Trigo ◽  
C Ruiz ◽  
GG Ribas ◽  
...  
Keyword(s):  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Double Blind

scholarly journals A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma

Cancer ◽  
1999 ◽  
Vol 85 (4) ◽  
pp. 786-795 ◽  
Author(s):  
Mace L. Rothenberg ◽  
John V. Cox ◽  
Russell F. DeVore ◽  
John D. Hainsworth ◽  
Richard Pazdur ◽  
...  
Keyword(s):  
Colorectal Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Multicenter Phase ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document